Aidia Investment Group, owner of RTP-based Invitrox, assays $500K in equity

Research Triangle Park-based Aidia Investment Group, which owns Invitrox Technologies, has raised $500,000 in new equity. Invitrox, which is commercializing technology developed at the University of North Carolina at Chapel Hill, develops diagnostic and therapeutic assays it says have a higher degree of specificity and sensitivity than current methods.

Read More